Mirapexin prolonged release formulation launched

A once daily formulation of pramipexole (Mirapexin Prolonged Release) has been launched for the treatment of idiopathic Parkinson's disease.

The new preparation is available in five strengths: 0.26mg, 0.52mg, 1.05mg, 2.1mg and 3.15mg.
Treatment with Mirapexin Prolonged Release should be initiated at 0.26mg daily, increasing to a maximum of 3.15mg per day as necessary.

View Mirapexin drug record

Further information: Boehringer

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

NICE updates sciatica treatment guidance

NICE updates sciatica treatment guidance

Updated NICE guidance on sciatica advises against the...

Drug shortages - live tracker

Drug shortages - live tracker

Use our constantly updated shortages tracker to check...

Live updates: Coronavirus (COVID-19) in the UK

Live updates: Coronavirus (COVID-19) in the UK

Use our timeline to follow the latest coronavirus developments...

Stop withdrawal of bipolar disorder treatment, health secretary urged

Stop withdrawal of bipolar disorder treatment, health secretary urged

GPs, pharmacists, psychiatrists and patients are calling...